EPENDYMOMA
Clinical trials for EPENDYMOMA explained in plain language.
Never miss a new study
Get alerted when new EPENDYMOMA trials appear
Sign up with your email to follow new studies for EPENDYMOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Lab test aims to match brain tumor patients with effective drugs
Disease control Not yet recruitingThis study is testing a personalized approach to find treatments for brain tumors that have stopped responding to standard therapies. Doctors will test tumor cells from surgery in a lab to see which drugs might work best for each patient. The goal is to see if this 'drug-matching…
Matched conditions: EPENDYMOMA
Phase: PHASE2 • Sponsor: University of Zurich • Aim: Disease control
Last updated Mar 27, 2026 12:39 UTC
-
New vaccine trial offers hope for kids with devastating brain tumors
Disease control Not yet recruitingThis study is testing a new combination treatment for children and young adults with aggressive brain cancers that have returned or are newly diagnosed. The treatment combines a vaccine designed to train the immune system to attack the cancer with a drug (nivolumab) that helps th…
Matched conditions: EPENDYMOMA
Phase: PHASE1, PHASE2 • Sponsor: Washington University School of Medicine • Aim: Disease control
Last updated Mar 27, 2026 12:39 UTC
-
Virus injected into brain to fight deadly childhood tumors
Disease control Not yet recruitingThis study is testing a new treatment for aggressive brain tumors that have come back or stopped responding to standard treatments in children and young adults. It involves a single injection of a modified virus (DNX-2401) directly into the tumor during a biopsy procedure. The ma…
Matched conditions: EPENDYMOMA
Phase: PHASE2 • Sponsor: Clinica Universidad de Navarra, Universidad de Navarra • Aim: Disease control
Last updated Mar 23, 2026 15:15 UTC
-
New 'Living Drug' trial offers hope for kids with tough brain cancers
Disease control Not yet recruitingThis early-stage study is testing a new type of personalized cell therapy called B7-H3 CAR T cells in children and young adults whose brain tumors have come back or gotten worse. The main goals are to find a safe dose and see if the body can successfully make the treatment. Parti…
Matched conditions: EPENDYMOMA
Phase: PHASE1 • Sponsor: Robbie Majzner • Aim: Disease control
Last updated Mar 19, 2026 14:56 UTC